English
Home > Products > CAS NO:105355-26-8

China CAS NO:105355-26-8 Factory

Our solutions are greatly recognized and reliable by customers and will fulfill continuously altering financial and social requirements for CAS NO:105355-26-8, The continual availability of substantial grade products and solutions in combination with our fantastic pre- and after-sales services ensures strong competitiveness in an increasingly globalized current market.
CAS NO:105355-26-8, Now, we professionally supplies customers with our main products And our business is not only the "buy" and "sell", but also focus on more. We target to be your loyal supplier and long-term cooperator in China. Now, We hope to be the friends with you.

Related Products

Hot Products

  • Atorvastatin tert-Butyl Ester

    Atorvastatin tert-Butyl Ester

    Product Name:Atorvastatin tert-Butyl Ester
    Molecular Formula:C37H43FN2O5
    Molecular Weight:614.75
    CAS Registry Number:134395-00-9
  • Phenylbutazone

    Phenylbutazone

    Product Name:Phenylbutazone
    Molecular Formula:C19H20N2O2
    Molecular Weight;308.37
    CAS Registry Number;50-33-9
  • LANTHANUM CARBONATE

    LANTHANUM CARBONATE

    Product Name:LANTHANUM CARBONATE
    Molecular Formula:C3La2O9
    Molecular Weight:457.84
    CAS Registry Number:587-26-8
  • trans-4-Hydroxy-L-proline methyl ester hydrochloride

    trans-4-Hydroxy-L-proline methyl ester hydrochloride

    Product Name:trans-4-Hydroxy-L-proline methyl ester hydrochloride
    Molecular Formula:C6H12ClNO3
    Molecular Weight:181.62
    CAS Registry Number:40216-83-9
  • Vitamin B12 Injection

    Vitamin B12 Injection

    Product Name:Vitamin B12 Injection
    Dosage:1mg/2ml
    Application:Vitamin
  • Canagliflozin hemihydrate

    Canagliflozin hemihydrate

    Product Name:Canagliflozin hemihydrate
    Molecular Formula:2(C24H25FO5S).H2O
    Molecular Weight;462.53
    CAS Registry Number;928672-86-0
  • Related Blog
  • Reviews

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept